Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Eton Pharmaceuticals Inc. (ETON) Misses Q2 EPS by 14c
August 11, 2022 4:05 PM EDTEton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q2 EPS of ($0.06), $0.14 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $7.4 million versus the consensus estimate of $9.5 million.
For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.
... More